PepsiCo faces mounting pressure to deliver the growth and margin targets it set after activist investor Elliott Investment Management took a stake of about $4 billion in the company. The threat from GLP-1 weight-loss drugs to its salty snacks and sugary drinks is growing. The company reports its third-quarter results on Thursday, October 8.
All eyes on Thursday will be on PepsiCo's North America business, where volumes have fallen, according to a Reuters report. CEO Ramon Laguarta is dealing with higher input costs linked to the Iran war, and sticky inflation is hurting consumer demand. Elliott built its stake in September 2025 and pushed the company to improve its performance in North America.
